Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: tonyt who wrote (1174)	3/2/1998 7:21:00 PM
From: Jonathan M. Traxler	Read Replies (1) \| Respond to of 2173

Stupid question, but can they pull it off without J&J

To: tonyt who wrote (1174)	3/2/1998 7:35:00 PM
From: jbershad	Respond to of 2173

To all, read the press release carefully. It looks to me like J&J has pulled out on expections of market and or better immediate chances somewhere else. There remains the question of what J&J will do with all their many shares of AMLN? Research is going forward. One solution for J&J maybe to sell shares to another big drug Co. What is book value? Tony I agree with you, everybody knew but us. Anybody have after close quotes on stock? Although it means nothing. I will check Murphy later. (Useless.) From what I read it is not all over for company. Jerry